Tisdale James E, Jaynes Heather A, Overholser Brian R, Sowinski Kevin M, Fisch Mark D, Rodgers Jo E, Aldemerdash Ahmed, Hsu Chia-Chi, Wang Nan, Muensterman Elena Tomaselli, Rao Vijay U, Kovacs Richard J
Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, Indiana; Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana.
Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, Indiana.
J Card Fail. 2020 Sep;26(9):781-785. doi: 10.1016/j.cardfail.2020.06.008. Epub 2020 Jun 24.
Patients with heart failure (HF) with reduced ejection fraction demonstrate enhanced response to drug-induced QT interval lengthening and are at increased risk for torsades de pointes. The influence of HF with preserved ejection fraction (HFpEF) on response to drug-induced QT lengthening is unknown.
We administered intravenous ibutilide 0.003 mg/kg to 10 patients with HFpEF and 10 age- and sex-matched control subjects without HF. Serial 12-lead electrocardiograms were obtained for determination of QT intervals. Demographics, maximum serum ibutilide concentrations, area under the serum ibutilide concentration vs time curves, and baseline Fridericia-corrected QT (QT) (417 ± 14 vs 413 ± 15 ms, P = .54) were similar in the HFpEF and control groups. Area under the effect (QTvs time) curve (AUEC) from 0 to 1.17 hours during and following the ibutilide infusion was greater in the HFpEF group (519 ± 19 vs 497 ± 18 ms·h, P= .04), as was AUEC from 0 to 8.17 hours (3576 ± 125 vs 3428 ± 161 ms·h, P = .03) indicating greater QT interval exposure. Maximum QT (454 ± 15 vs 443 ± 22 ms, P = .18) and maximum percent increase in QT from baseline (8.2 ± 2.1 vs 6.7 ± 1.9%, P = .10) in the 2 groups were not significantly different.
HFpEF is associated with enhanced response to drug-induced QT interval lengthening.
射血分数降低的心力衰竭(HF)患者对药物诱导的QT间期延长表现出增强的反应,且发生尖端扭转型室速的风险增加。射血分数保留的心力衰竭(HFpEF)对药物诱导的QT延长反应的影响尚不清楚。
我们对10例HFpEF患者和10例年龄及性别匹配的无HF对照受试者静脉注射0.003 mg/kg伊布利特。获取连续12导联心电图以测定QT间期。HFpEF组和对照组的人口统计学、伊布利特最大血清浓度、血清伊布利特浓度-时间曲线下面积以及基线弗里德里西亚校正QT(QTc)(417±14 vs 413±15 ms,P = 0.54)相似。伊布利特输注期间及之后0至1.17小时的效应(QTc-时间)曲线下面积(AUEC)在HFpEF组更大(519±19 vs 497±18 ms·h,P = 0.04),0至8.17小时的AUEC也是如此((3576±125 vs 3428±161 ms·h,P = 0.03),表明QT间期暴露更多。两组的最大QTc(454±15 vs 443±22 ms,P = 0.18)和QTc相对于基线的最大百分比增加(8.2±2.1 vs 6.7±1.9%,P = 0.10)无显著差异。
HFpEF与药物诱导的QT间期延长反应增强有关。